Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Small Volume Parenterals (SVP) market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Small Volume Parenterals (SVP) market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Small Volume Parenterals (SVP) market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Small Volume Parenterals (SVP) products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Small Volume Parenterals (SVP) products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Small Volume Parenterals (SVP) market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Small Volume Parenterals (SVP) development has been the leading industry trend of Small Volume Parenterals (SVP) market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Small Volume Parenterals (SVP) Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Ampules,Vials,Prefilled Syringes, Other |
| By Application Outlook |
Local Anesthetics,Vaccines,Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Allergan,Bayer,GSK,J&J,Pfizer,Teva,Novartis |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Allergan
- Bayer
- GSK
- J&J
- Pfizer
- Teva
- Novartis
Small Volume Parenterals (SVP) Market, By Type
- Ampules
- Vials
- Prefilled Syringes
- Other
Small Volume Parenterals (SVP) Market, By Application
- Local Anesthetics
- Vaccines
- Other
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Small Volume Parenterals (SVP) Market Size Growth Rate by Type (2019-2025)
1.3.2 Ampules
1.3.3 Vials
1.3.4 Prefilled Syringes
1.4 Market Segment by Application
1.4.1 Global Small Volume Parenterals (SVP) Market Share by Application (2019-2025)
1.4.2 Local Anesthetics
1.4.3 Vaccines
1.4.4 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Small Volume Parenterals (SVP) Production Value 2014-2025
2.1.2 Global Small Volume Parenterals (SVP) Production 2014-2025
2.1.3 Global Small Volume Parenterals (SVP) Capacity 2014-2025
2.1.4 Global Small Volume Parenterals (SVP) Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2019-2025
2.2.1 Global Small Volume Parenterals (SVP) Market Size CAGR of Key Regions
2.2.2 Global Small Volume Parenterals (SVP) Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Small Volume Parenterals (SVP) Capacity by Manufacturers
3.1.2 Global Small Volume Parenterals (SVP) Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Small Volume Parenterals (SVP) Revenue by Manufacturers (2014-2019)
3.2.2 Small Volume Parenterals (SVP) Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Small Volume Parenterals (SVP) Market Concentration Ratio (CR5 and HHI)
3.3 Small Volume Parenterals (SVP) Price by Manufacturers
3.4 Key Manufacturers Small Volume Parenterals (SVP) Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Small Volume Parenterals (SVP) Market
3.6 Key Manufacturers Small Volume Parenterals (SVP) Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Ampules Production and Production Value (2014-2019)
4.1.2 Vials Production and Production Value (2014-2019)
4.1.3 Prefilled Syringes Production and Production Value (2014-2019)
4.2 Global Small Volume Parenterals (SVP) Production Market Share by Type
4.3 Global Small Volume Parenterals (SVP) Production Value Market Share by Type
4.4 Small Volume Parenterals (SVP) Ex-factory Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Small Volume Parenterals (SVP) Consumption by Application
6 Production by Regions
6.1 Global Small Volume Parenterals (SVP) Production (History Data) by Regions 2014-2019
6.2 Global Small Volume Parenterals (SVP) Production Value (History Data) by Regions
6.3 United States
6.3.1 United States Small Volume Parenterals (SVP) Production Growth Rate 2014-2019
6.3.2 United States Small Volume Parenterals (SVP) Production Value Growth Rate 2014-2019
6.3.3 Key Players in United States
6.3.4 United States Small Volume Parenterals (SVP) Import & Export
6.4 European Union
6.4.1 European Union Small Volume Parenterals (SVP) Production Growth Rate 2014-2019
6.4.2 European Union Small Volume Parenterals (SVP) Production Value Growth Rate 2014-2019
6.4.3 Key Players in European Union
6.4.4 European Union Small Volume Parenterals (SVP) Import & Export
6.5 China
6.5.1 China Small Volume Parenterals (SVP) Production Growth Rate 2014-2019
6.5.2 China Small Volume Parenterals (SVP) Production Value Growth Rate 2014-2019
6.5.3 Key Players in China
6.5.4 China Small Volume Parenterals (SVP) Import & Export
6.6 Rest of World
6.6.1 Japan
6.6.2 Korea
6.6.3 India
6.6.4 Southeast Asia
7 Small Volume Parenterals (SVP) Consumption by Regions
7.1 Global Small Volume Parenterals (SVP) Consumption (History Data) by Regions
7.2 United States
7.2.1 United States Small Volume Parenterals (SVP) Consumption by Type
7.2.2 United States Small Volume Parenterals (SVP) Consumption by Application
7.3 European Union
7.3.1 European Union Small Volume Parenterals (SVP) Consumption by Type
7.3.2 European Union Small Volume Parenterals (SVP) Consumption by Application
7.4 China
7.4.1 China Small Volume Parenterals (SVP) Consumption by Type
7.4.2 China Small Volume Parenterals (SVP) Consumption by Application
7.5 Rest of World
7.5.1 Rest of World Small Volume Parenterals (SVP) Consumption by Type
7.5.2 Rest of World Small Volume Parenterals (SVP) Consumption by Application
7.5.1 Japan
7.5.2 Korea
7.5.3 India
7.5.4 Southeast Asia
8 Company Profiles
8.1 Allergan
8.1.1 Allergan Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Small Volume Parenterals (SVP)
8.1.4 Small Volume Parenterals (SVP) Product Introduction
8.1.5 Allergan Recent Development
8.2 Bayer
8.2.1 Bayer Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Small Volume Parenterals (SVP)
8.2.4 Small Volume Parenterals (SVP) Product Introduction
8.2.5 Bayer Recent Development
8.3 GSK
8.3.1 GSK Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Small Volume Parenterals (SVP)
8.3.4 Small Volume Parenterals (SVP) Product Introduction
8.3.5 GSK Recent Development
8.4 J&J
8.4.1 J&J Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Small Volume Parenterals (SVP)
8.4.4 Small Volume Parenterals (SVP) Product Introduction
8.4.5 J&J Recent Development
8.5 Pfizer
8.5.1 Pfizer Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Small Volume Parenterals (SVP)
8.5.4 Small Volume Parenterals (SVP) Product Introduction
8.5.5 Pfizer Recent Development
8.6 Teva
8.6.1 Teva Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Small Volume Parenterals (SVP)
8.6.4 Small Volume Parenterals (SVP) Product Introduction
8.6.5 Teva Recent Development
8.7 Novartis
8.7.1 Novartis Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Small Volume Parenterals (SVP)
8.7.4 Small Volume Parenterals (SVP) Product Introduction
8.7.5 Novartis Recent Development
9 Market Forecast
9.1 Global Market Size Forecast
9.1.1 Global Small Volume Parenterals (SVP) Capacity, Production Forecast 2019-2025
9.1.2 Global Small Volume Parenterals (SVP) Production Value Forecast 2019-2025
9.2 Market Forecast by Regions
9.2.1 Global Small Volume Parenterals (SVP) Production and Value Forecast by Regions 2019-2025
9.2.2 Global Small Volume Parenterals (SVP) Consumption Forecast by Regions 2019-2025
9.3 United States
9.3.1 Production and Value Forecast in United States
9.3.2 Consumption Forecast in United States
9.4 European Union
9.4.1 Production and Value Forecast in European Union
9.4.2 Consumption Forecast in European Union
9.5 China
9.5.1 Production and Value Forecast in China
9.5.2 Consumption Forecast in China
9.6 Rest of World
9.6.1 Japan
9.6.2 Korea
9.6.3 India
9.6.4 Southeast Asia
9.7 Forecast by Type
9.7.1 Global Small Volume Parenterals (SVP) Production Forecast by Type
9.7.2 Global Small Volume Parenterals (SVP) Production Value Forecast by Type
9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
10.1 Value Chain Analysis
10.2 Sales Channels Analysis
10.2.1 Small Volume Parenterals (SVP) Sales Channels
10.2.2 Small Volume Parenterals (SVP) Distributors
10.3 Small Volume Parenterals (SVP) Customers
11 Opportunities & Challenges, Threat and Affecting Factors
11.1 Market Opportunities
11.2 Market Challenges
11.3 Porter's Five Forces Analysis
12 Key Findings
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
